MOVAPO

paladin pharma inc.🇨🇦 Health Canada

Approval Id: 82756b72d56b371a
Drug Approval Canada Name: MOVAPO
Product Name: MOVAPO
Status: Cancelled Post Market
Status Date: 2023-10-23
Original Market Date: 2017-09-07
Din: 02459132
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription
Ahfs: 28:36.20.08
Atc Original: N04BC07 APOMORPHINE
Atc Name: n 04 bc 07
Aig Number: 0158570001
Company Name: paladin pharma inc.
Company Address: 100 Blvd Alexis-Nihon, Suite 600, Montreal, Quebec, Canada, H4M 2P2

APOMORPHINE HYDROCHLORIDE

10 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

82756b72d56b371a

Type

Standard